Therapeutic Approaches to Type 2 Diabetes

---

Diabetes Care - Volume 22 Supplement 3, April 1999

Therapeutic Approaches to Type 2 Diabetes

Proceedings from a Conference Sponsored by the Indiana University Diabetes Research and Training Center

Scottsdale, Arizona
10–12 December 1997

C1  Therapeutic approaches to type 2 diabetes
C.M. Clark, Jr.

Full Text - No purchase necessary

C2  Natural history of macrovascular disease in type 2 diabetes: role of insulin resistance
M. Stern

Full Text - No purchase necessary

C6  Risk factors for macrovascular disease in type 2 diabetes: classic lipid abnormalities
G. Steiner

Full Text - No purchase necessary

C10  Dyslipidemia of central obesity and insulin resistance
J.D. Brunzell, J.E. Hokanson

Full Text - No purchase necessary

C14  Diabetes and cardiovascular disease
J.R. Sowers, M.A. Lester

Full Text - No purchase necessary

C21  Natural history of macrovascular disease and classic risk factors for atherosclerosis: session summary
R.H. Eckel

Full Text - No purchase necessary

C25  Abnormalities of coagulation and fibrinolysis in insulin resistance: evidence for a common antecedent?
J.S. Yudkin

Abstract - Full Text

C31  Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes
G.L. King, H. Wakasaki

Full Text - No purchase necessary

C38  Insulin resistance and hyperglycemic associated risk factors: session summary
J.-P. Des

Full Text - No purchase necessaryt

C41Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes
H.E. Lebovitz

Abstract -Full Text

C45  Effect of insulin therapy on macrovascular risk factors in type 2 diabetes
M.S. Boyne, C.D. Saudek

Abstract - Full Text

C54  Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes
S.M. Haffner

Abstract -Full Text

C57  Impact of glucose control in type 2 diabetes: session summary
M.P. Stern

Full Text - No purchase necessary

C61  Oral agent therapy in the treatment of type 2 diabetes
M.N. Feinglos, M.A. Bethel

Full Text - No purchase necessary

C65  Overview of current therapeutic options in type 2 diabetes: rationale for combining oral agents with insulin therapy
J.B. Buse

Full Text - No purchase necessary

C71  Rationale for the use of insulin therapy alone as the pharmacological treatment of type 2 diabetes
M. Berger, V.

Abstract - Full Text

C76  Overview of current therapeutic options: session summary
M.C. Riddle

Full Text - No purchase necessary

C79   Conclusion
C.M. Clark, Jr.

Full Text - No purchase necessary

SI Units Table

Full Text (No purchase necessary)